Sandra Schaerer and Karolina Snajdarova are Regulatory Affairs Managers at Ypsomed. We spoke with them about where programmes actually slow down on the device si...

The revised EU GMP Annex 1 has rapidly become one of the most influential regulatory updates in sterile medicinal product manufacturing. Its impact is global, it...

Aurisco, the first USFDA inspected generic oligonucleotide API manufacturer is innovating in enzymatic ligation, hybrid solid and liquid phase synthesis, GLP-1 p...

Antibody-Drug Conjugates (ADCs) represent one of the most powerful and complex classes of cancer therapies ever developed – combining the precision of a monoclon...

Oral drug delivery remains one of the most important and widely adopted routes of administration in pharmaceutical development. Tablets and capsules continue to ...

Highly potent APIs are becoming more significant across the pharmaceutical development pipeline. Market estimates vary, but the direction is consistent: the glob...

Artificial intelligence (AI) is beginning to influence many aspects of pharmaceutical development, including areas once thought too specialist or product-specifi...

Pharmaceutical packaging occupies a critical position in the product lifecycle. From both a regulatory and quality control perspective, it is a critical componen...

Child-resistant packaging is an important consideration in the development and commercialisation of certain pharmaceutical products. Its fundamental purpose is t...

International Pharmaceutical Industry Journal speaks with Edouard Pagnoud, Product Line Manager – Vial Stoppers at Aptar Pharma, about the evolving expectations ...